TARIS Biomedical Obtains $15,000,000 Series A Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4bd9322e-60fb-4710-aecd-98dd20e516ba&Preview=1 -
Date
6/24/2009 -
Company Name
TARIS Biomedical -
Mailing Address
99 Hayden Avenue Lexington, MA 02421 -
Company Description
TARIS Biomedical Inc., a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products. The TARIS core technology and development efforts are being applied to disease areas with high unmet medical need in which current therapies or systemic treatments have failed. TARIS Biomedical has several drug-device convergence program opportunities focused on addressing those underserved disease areas through local delivery of therapeutics, with an initial focus on bladder diseases including Interstitial Cystitis (IC)/Painful Bladder Syndrome (PBS) -
Website
http://www.tarisbiomedical.com -
Transaction Type
Venture Equity -
Transaction Amount
$15,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Flagship Ventures -
Venture Investor
Flybridge Capital Partners -
Venture Investor
Polaris Venture Partners
